Latest Earnings Results: Q2 '26
Estimated EPS
$0.03
Reported EPS
$0.06
Surprise
+83.21%
Estimated Rev
$414.58M
Reported Rev
$435.35M
Surprise
+5.01%
• Reported GAAP EPS of $0.06 up 700.00% YoY • Reported revenue of $435.35M up 26.08% YoY • LifeStance Health Group, Inc. is raising full year 2026 revenue expectations to $1.685 billion to $1.725 billion, Center Margin to $570 million to $594 million, and Adjusted EBITDA to $215 million to $235 million.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.04 | -- | -- | N/A |
Q2 '26 | $0.03 | $0.06 | 83.21% | BEAT |
Q1 '26 | $0.01 | $0.04 | 457.18% | BEAT |
Q4 '25 | $0.00 | $0.01 | 191.29% | BEAT |
Q3 '25 | -$0.01 | $0.00 | 100.00% | BEAT |